Trial Profile
Phase I trial of NAS 911IPF in patients with idiopathic pulmonary fibrosis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs NAS-911 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Sponsors New Amsterdam Sciences
- 24 Sep 2014 New trial record
- 21 Aug 2014 New Amsterdam Sciences is advancing NAS 911IPF into phase I trials and preparing to submit an IND, according to a media release.